bromodeoxyuridine has been researched along with Rheumatoid Arthritis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bell, RD; Kenney, HM; Peng, Y; Ritchlin, CT; Schwarz, EM; Wood, RW; Xing, L | 1 |
Brzana, W; Jabłoński, M; Majdan, M; Mitura, A; Parada-Turska, J; Rzeski, W | 1 |
Hwang, JK; Jang, KY; Koh, HW; Lee, JH; Lee, YR; Park, BH; Park, JW | 1 |
Chen, Z; Ding, J; Fan, C; Li, X; Wang, H; Wang, Y; Zhu, P | 1 |
Inoue, K; Inoue, Y; Kanbe, K; Suzuki, Y | 1 |
Bijlsma, JW; Damen, CA; Duursma, SA; Lafeber, FP; Scheven, BA; van der Veen, MJ; Van Rijn, HJ | 1 |
1 trial(s) available for bromodeoxyuridine and Rheumatoid Arthritis
Article | Year |
---|---|
Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis.
Topics: Aged; Antibodies, Monoclonal; Antigens, CD20; Antirheumatic Agents; Arthritis, Rheumatoid; Bromodeoxyuridine; Female; Humans; Immunohistochemistry; Infliximab; Interleukin-6; Male; Matrix Metalloproteinase 3; Methotrexate; Middle Aged; NF-kappa B; Synovial Membrane; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2008 |
5 other study(ies) available for bromodeoxyuridine and Rheumatoid Arthritis
Article | Year |
---|---|
Persistent popliteal lymphatic muscle cell coverage defects despite amelioration of arthritis and recovery of popliteal lymphatic vessel function in TNF-Tg mice following anti-TNF therapy.
Topics: Animals; Antibodies, Monoclonal; Arthritis, Rheumatoid; Bromodeoxyuridine; Lymphatic Vessels; Mice; Mice, Transgenic; Muscle Cells; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; X-Ray Microtomography | 2022 |
Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro.
Topics: Animals; Arthritis, Rheumatoid; Bromodeoxyuridine; Cell Line; Cell Proliferation; Fibroblasts; Humans; Hyperplasia; Phytotherapy; Rabbits; Sesquiterpenes; Synovial Membrane; Tanacetum parthenium; Tetrazolium Salts; Thiazoles | 2008 |
Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice.
Topics: Animals; Antimetabolites; Arthritis, Rheumatoid; Benzofurans; Blotting, Western; Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Chemokines; Collagen; Cytokines; Electrophoretic Mobility Shift Assay; Flavonoids; In Vitro Techniques; Male; Matrix Metalloproteinases; Mice; Mice, Inbred DBA; NF-kappa B; Osteoclasts; Rhus; Synovial Membrane; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2012 |
Simultaneous detection of DNA synthesis, activation and cytokine secretion in collagen II (250-270)-activated T lymphocytes by flow cytometry.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Arthritis, Rheumatoid; Bromodeoxyuridine; Case-Control Studies; Cell Proliferation; Collagen Type II; Cytokines; DNA; Female; Flow Cytometry; Humans; Lectins, C-Type; Lymphocyte Activation; Male; Middle Aged; Peptide Fragments; Receptors, Interleukin-2; Sensitivity and Specificity; T-Lymphocytes | 2004 |
Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Topics: Alkaline Phosphatase; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Remodeling; Bromodeoxyuridine; Calcitriol; Cell Differentiation; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Femur Head; Humans; Immunohistochemistry; Methotrexate; Osteoblasts; Osteocalcin; Radioimmunoassay | 1995 |